BioSpace News Archive

Brooklyn ImmunoTherapeutics , Inc. today announced the appointment of Kevin A. D’Amour, Ph.D. as its Chief Scientific Officer.

OneThree Biotech today announced a collaboration with Sun Pharma Advanced Research Company Ltd. to enhance understanding of the biological mechanisms driving a key oncologic disease pathway.

Incyte Announces U.S. FDA Has Extended the sNDA Review Period for Ruxolitinib (Jakafi ® ) in Chronic Graft-Versus-Host Disease (GVHD).

Nascent Biotech, Inc. is pleased to announce the beginning of enrollment of the second cohort in dosing patients for its Phase I trial for Brain Cancer.

Chinook Therapeutics today announced the presentation of data from the ongoing phase 1/2 study of BION-1301 in patients with IgAN.

GBS Inc. (Nasdaq: GBS), today announced survey results from more than 300 patients globally as part of its development and go-to-market strategy.

Company offers preview of extraction protocol selected as a finalist for XPRIZE Rapid COVID Testing Competition.

FDA’s Fast Track Designation for VBI-1901 underscores the significant and urgent unmet medical need for new therapies for recurrent glioblastoma (GBM) patients.

Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, provided an update regarding its application for a Healthcare Common Procedure Coding System Level II code change and benefit category redetermination for HCPCS codes L8701 and L8702 submitted in January 2021.

IASO Biotherapeutics and Innovent Biologics, Inc. jointly announced the delivery of an oral presentation on updated data from the Phase I study of CT103A in patients with myeloma.